{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:58Z","timestamp":1777865278192,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011658","name":"French Infrastructure for Integrated Structural Biology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["SPS ANR-17-EUR-0007"],"award-info":[{"award-number":["SPS ANR-17-EUR-0007"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-INBS-0015"],"award-info":[{"award-number":["ANR-24-INBS-0015"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE18-0016-01"],"award-info":[{"award-number":["ANR-20-CE18-0016-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-SEBM-0001-01"],"award-info":[{"award-number":["ANR-20-SEBM-0001-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018833","name":"French Government Defense Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","award":["91198"],"award-info":[{"award-number":["91198"]}],"id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","award":["FBI ANR-24-INBS-0005"],"award-info":[{"award-number":["FBI ANR-24-INBS-0005"]}],"id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118645","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:55:07Z","timestamp":1770278107000},"page":"118645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and biological evaluation of Retro-2-based PROTACs reveal PEG-linker length and warhead impact on GSPT1 degradation"],"prefix":"10.1016","volume":"307","author":[{"given":"Marine","family":"Michon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Curpanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ombeline","family":"Pessey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Herbette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hinsinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Armengaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Cintrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-4973","authenticated-orcid":false,"given":"Julien","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118645_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-021-00245-x","article-title":"The PROTACtable genome,","volume":"20","author":"Schneider","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118645_bib2","article-title":"Targeted protein degradation in cancers: orthodox PROTACs and beyond","volume":"4","author":"Li","year":"2023","journal-title":"Innovation"},{"key":"10.1016\/j.ejmech.2026.118645_bib3","article-title":"The application of PROTACs in immune-inflammation diseases, Bioorg","volume":"115","author":"Zhang","year":"2024","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107386","article-title":"Research progress of PROTACs for neurodegenerative diseases therapy","volume":"147","author":"Cai","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib5","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1038\/d41591-024-00072-8","article-title":"PROTAC protein degraders to drug the undruggable enter phase 3 trials","volume":"30","author":"Arnold","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.ejmech.2026.118645_bib6","doi-asserted-by":"crossref","first-page":"D1510","DOI":"10.1093\/nar\/gkae768","article-title":"PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters","volume":"53","author":"Ge","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118645_bib7","article-title":"The discovery of protheolysis targeting Chimeras (PROTACs), evolution, design and perspectives in modulating inflammatory diseases,","volume":"35","author":"Caruso","year":"2024","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118645_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111185","article-title":"Molecular mechanisms of cereblon-interacting small molecules in multiple myeloma therapy","volume":"11","author":"Costacurta","year":"2021","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.ejmech.2026.118645_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118645_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15398","article-title":"pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase","volume":"8","author":"An","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118645_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-62099-w","article-title":"Unveiling the hidden interactome of CRBN molecular glues","volume":"16","author":"Baek","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118645_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt6736","article-title":"Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition","volume":"389","author":"Petzold","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118645_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase,","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118645_bib14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acs.jmedchem.0c01489","article-title":"CC-90009: a cereblon E3 ligase modulating drug that promotes selective degradation of GSPT1 for the treatment of Acute Myeloid leukemia,","volume":"64","author":"Hansen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.118645_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153514","article-title":"Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells","volume":"132","author":"Sellar","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118645_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15212\/AMM-2024-0010","article-title":"Application of PROTACs in target identification and target validation","volume":"3","author":"Liu","year":"2024","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.ejmech.2026.118645_bib18","article-title":"Degradation-based protein profiling: a case Study of celastrol","volume":"11","author":"Ni","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ejmech.2026.118645_bib19","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acs.jmedchem.3c00824","article-title":"Facilitated drug repurposing with artemisinin-derived PROTACs: unveiling PCLAF as a therapeutic target","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib20","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.apsb.2022.07.007","article-title":"PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118645_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jare.2023.10.014","article-title":"PROTAC derivatization of natural products for target identification and drug discovery: design of evodiamine-based PROTACs as novel REXO4 degraders","volume":"63","author":"Chen","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.118645_bib22","article-title":"Identification of PDE6D as a potential target of sorafenib via PROTAC technology","author":"Li","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.118645_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-39657-1","article-title":"Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1","volume":"14","author":"Bagka","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118645_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","article-title":"Inhibition of retrograde transport protects mice from lethal ricin challenge","volume":"141","author":"Stechmann","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118645_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/ml400457j","article-title":"(S)-N-Methyldihydroquinazolinones are the active enantiomers of Retro-2 derived compounds against toxins","volume":"5","author":"Gupta","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118645_bib26","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1021\/jm4002346","article-title":"N-methyldihydroquinazolinone derivatives of Retro-2 with enhanced efficacy against Shiga toxin","volume":"56","author":"Noel","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib27","doi-asserted-by":"crossref","first-page":"10120","DOI":"10.1128\/JVI.01464-16","article-title":"Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during virus morphogenesis","volume":"90","author":"Harrison","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.118645_bib28","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/JVI.02520-14","article-title":"Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction","volume":"89","author":"Nonnenmacher","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.118645_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.antiviral.2017.07.001","article-title":"Antiviral effects of Retro-2(cycl) and Retro-2.1 against Enterovirus 71 in vitro and in vivo","volume":"144","author":"Dai","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2026.118645_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010415","article-title":"A new derivative of Retro-2 displays antiviral activity against respiratory syncytial virus, int","volume":"25","author":"Le Rouzic","year":"2023","journal-title":"J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118645_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/mmi.13222","article-title":"Proteomic analysis of the Simkania-containing vacuole: the central role of retrograde transport,","volume":"99","author":"Herweg","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118645_bib32","article-title":"Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections, PLoS Negl. Trop","volume":"11","author":"Craig","year":"2017","journal-title":"Dis"},{"key":"10.1016\/j.ejmech.2026.118645_bib33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ajpath.2012.06.041","article-title":"Targeting host syntaxin-5 preferentially blocks leishmania parasitophorous vacuole development in infected cells and limits experimental leishmania infections","volume":"181","author":"Canton","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2026.118645_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48434","article-title":"Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteins","volume":"8","author":"Morgens","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.118645_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41589-020-0474-4","article-title":"Functional dissection of the retrograde Shiga toxin trafficking inhibitor Retro-2","volume":"16","author":"Forrester","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118645_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2020.152719","article-title":"Synthesis of amide derivatives for electron deficient amines and functionalized carboxylic acids using EDC and DMAP and a catalytic amount of HOBt as the coupling reagents","volume":"63","author":"Ghosh","year":"2021","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2026.118645_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.37349\/etat.2020.00018","article-title":"Current strategies for the design of PROTAC linkers: a critical review","volume":"1","author":"Troup","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.ejmech.2026.118645_bib38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/acsmedchemlett.1c00368","article-title":"Influence of linker attachment points on the stability and neosubstrate degradation of cereblon ligands","volume":"12","author":"Bricelj","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118645_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.1965.tb02053.x","article-title":"The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution, Br","volume":"25","author":"Schumacher","year":"1965","journal-title":"J. Pharmacol. Chemother"},{"key":"10.1016\/j.ejmech.2026.118645_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/acschembio.7b00969","article-title":"Translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders","volume":"13","author":"Ishoey","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118645_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.toxicon.2012.07.016","article-title":"Shiga toxins","volume":"60","author":"Bergan","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ejmech.2026.118645_bib42","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/acs.jmedchem.4c01017","article-title":"Structural and physicochemical features of oral PROTACs","volume":"67","author":"Schade","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib43","article-title":"Exploring the chemical space of orally bioavailable PROTACs, Drug Discov","volume":"29","author":"Apprato","year":"2024","journal-title":"Today Off."},{"key":"10.1016\/j.ejmech.2026.118645_bib44","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/acs.jmedchem.9b00846","article-title":"Simple structural modifications converting a bona fide MDM2 PROTAC degrader into a molecular glue molecule: a cautionary tale in the design of PROTAC degraders,","volume":"62","author":"Yang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118645_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-024-01766-4","article-title":"The astounding exhaustiveness and speed of the Astral mass analyzer for highly complex samples is a quantum leap in the functional analysis of microbiomes,","volume":"12","author":"Dumas","year":"2024","journal-title":"Microbiome"},{"key":"10.1016\/j.ejmech.2026.118645_bib46","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1111\/1462-2920.14975","article-title":"Quick microbial molecular phenotyping by differential shotgun proteomics","volume":"22","author":"Gouveia","year":"2020","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2026.118645_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1039\/D0MO00087F","article-title":"Guide for protein fold change and p-value calculation for non-experts in proteomics","volume":"16","author":"Aguilan","year":"2020","journal-title":"Mol. Omics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:09:08Z","timestamp":1777529348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"alternative-id":["S0223523426000905"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118645","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of Retro-2-based PROTACs reveal PEG-linker length and warhead impact on GSPT1 degradation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118645"}}